Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy

Sorafenib is used worldwide as a first-line standard systemic agent for advanced hepatocellular carcinoma (HCC) on the basis of the results of two large-scale Phase III trials. Conversely, hepatic arterial infusion chemotherapy (HAIC) is one of the most recommended treatments in Japan. Although ther...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Hepatol
Hauptverfasser: Saeki, Issei, Yamasaki, Takahiro, Maeda, Masaki, Hisanaga, Takuro, Iwamoto, Takuya, Fujisawa, Koichi, Matsumoto, Toshihiko, Hidaka, Isao, Marumoto, Yoshio, Ishikawa, Tsuyoshi, Yamamoto, Naoki, Suehiro, Yutaka, Takami, Taro, Sakaida, Isao
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6177565/
https://ncbi.nlm.nih.gov/pubmed/30310535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i9.571
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge